The Department of Appeals and Licensing published its Pharma Phacts Newsletter (February 2026). Highlights include the following:
- New Jurisprudence Exam Starts April 1, 2026
- Prescription Management Program (PMP) Updates
- Compliance Corner
- Reminder to Keep License Profile Updated?
- Notification of Change of Pharmacist in Charge
- FDA Warns of Counterfeit Ozempic in US Drug Supply Chain
- Retatrutide in Iowa
- Reminder of Actions to Take After Identification of Fraudulent Controlled Substance Prescription
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
